Article
Genomics and new targets for multiple sclerosis.
Pharmacogenomics - 1 Mar 2005
Baranzini Sergio E, Oksenberg Jorge R
Abstract excerpt
Compelling epidemiological and molecular data indicate that genes play a primary role in determining who is at risk for developing multiple sclerosis (MS), how the disease progresses, and how MS individuals respond to therapy. The genetic component of MS etiology is believed to result from the action of allelic variants in several genes. Their incomplete penetrance and moderate individual effect probably reflects...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
